New oral cancer pill enters first human trials for Tough-to-Treat tumors
Disease control
Recruiting now
This is the first study in people to test a new oral medication called CID-078 for advanced solid tumors. The main goals are to find a safe dose and see how well the body handles the drug. The study will enroll adults with cancers like triple-negative breast cancer, small cell lu…
Phase: PHASE1 • Sponsor: Circle Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC